GLP-1 Facial Volume Change, What Ozempic Face Means
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
Ozempic face is a nickname for something that has always happened after rapid weight loss, and the medication has simply made it common enough to name.
This article explains what is actually going on, such as:
- Why the face changes before anywhere else
- The difference between hollowing and loosening
- Which part a home device can address
- What belongs in a conversation with your prescriber
and many more!
Nothing here is medical advice about your medication, and none of it is a reason to stop taking it.
Key Points:
Facial fat sits in small compartments that empty at different rates, so a modest loss reads as a large change.
Hollowing is lost volume, and nothing at home puts volume back.
Loosening is skin that has not fully retracted, and no device restores elastin.
Muscle is the one layer a device reaches, and rapid loss can affect muscle everywhere.
Protein intake and rate of loss belong with your prescriber, not with a beauty device.
Why the face goes first
Facial fat is arranged in distinct compartments rather than as one even layer, and those compartments are small, so losing a little reads as a lot.
They also empty at different rates, which is why the midface can hollow while the lower face still looks full, producing a drawn appearance rather than an evenly slimmer one.
Faster loss produces a more abrupt version of the same change, because the surrounding skin and ligaments have less time to adapt.
None of that is specific to GLP-1 medication, and it has been described after rapid loss from any cause for as long as anyone has been looking.
Two different changes, often at once
Hollowing is an absence, since the compartment under your cheek or temple holds less than it did, and nothing tightens an absence.
Loosening is a surplus, where the skin that covered a fuller face is still present and has not fully retracted.
How much it retracts depends on elastin, on your age when the loss happened and on how long the skin spent stretched, none of which is retrospectively adjustable.
Skin does continue to adapt for months, so the picture during active loss is not the final one, which is a reason not to make expensive decisions mid-course.
The layer a device can reach
Under the skin and fat sit around forty small muscles held in a connected sheet called the SMAS, and they contribute to how the face holds its shape.
Electrical muscle stimulation reaches that layer by firing the motor nerve, so the muscle contracts without any instruction from you.
Kavanagh 2012 followed 108 women using daily facial muscle stimulation for twelve weeks and ultrasound measured an 18.6 percent increase in cheek-muscle thickness, with a clear difference from the untreated group at six weeks (Kavanagh 2012).
That trial used its own device rather than a PureLift, and it studied a general population rather than anyone losing weight rapidly.
The part worth raising with your prescriber
Rapid weight loss can come with reduced protein intake and a loss of lean mass alongside fat, and muscle anywhere in the body responds poorly to that.
Working a facial muscle four times a week does not offset an overall protein deficit, so if your face is changing faster than you expected, that conversation belongs with whoever is managing your treatment.
Rate of loss is also adjustable in a way that facial anatomy is not, and slower loss gives skin more chance to keep up.
Nothing on this page is a reason to stop or change a prescribed medication, and that decision is not one a beauty brand should be influencing.
What a device will not do
It will not restore volume to an emptied fat compartment, which is what fillers and fat transfer exist for.
It will not remove excess skin, since that is a surgical question and muscle work does not shorten a surplus.
It will not slow the facial change while loss is ongoing, and the honest expectation during an active course is maintenance of the one layer you can work rather than prevention of the others.
If you want to use one anyway
Every PureLift model runs nanocurrent at level 1, microcurrent at level 2, EMS from level 3 to 10, and an Infuse pass carrying Infusion and iontophoresis on the serum already on your skin.
Three minutes on each side at the lowest level that gives a clear, comfortable contraction, about ten minutes in total, four times a week.
Judge it over a stable period rather than during active loss, since a face that is still changing week to week will not give you a readable comparison.
Anyone with a pacemaker or another implanted electronic device, anyone pregnant and anyone with epilepsy or a seizure disorder should not use an electrical facial device.